This work describes the structure and function of dynamin and clathrin in endocytosis across clathrin mediated and synaptic vesicle endocytosis; the potential role of SVE in neurological diseases and the current state of the art in developing CME (and SVE) inhibitors via targeting of dynamin and clathrin. This evidence concerns the gene DNM1 and nervous system disorder.